Judge Told NJ Punitive Curbs Don't Apply To Risperdal Suits

Law360, New York (June 13, 2014, 2:49 PM EDT) -- Plaintiffs challenging a Pennsylvania judge's decision barring them from asking for punitive damages in hundreds of coordinated injury suits over Johnson & Johnson's antipsychotic medication Risperdal argued Thursday that New Jersey's curbs on punitive damages don't necessarily apply to their suits.

In a brief filed in the Philadelphia County Court of Common Pleas, the plaintiffs argued that many of them had been treated with Risperdal for uses that the U.S. Food and Drug Administration had not approved, in which case, they claimed, the state's restriction of punitive damages in pharmaceutical liability cases would not apply.

Johnson & Johnson unit Janssen Pharmaceuticals...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!